FCPR Biotechnology Fund

Insider

First SEC filing: May 2, 2014 · Latest: May 2, 2014

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 14 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

14 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 7, 2014	SCYX	C	623,880	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
May 7, 2014	SCYX	C	863,672	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
May 7, 2014	SCYX	C	313,996	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
May 7, 2014	SCYX	C	166,482	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
May 7, 2014	SCYX	X	25,998	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
May 7, 2014	SCYX	X	5,251	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
May 7, 2014	SCYX	X	5,251	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
May 7, 2014	SCYX	P	50,000	$10.00	$500,000	295,077 Direct	+20.40%	Acquired	-99.3% (price as of 2026-08-20)
May 7, 2014	SCYX	C	30,582	—	—	245,077 Direct	+14.26%	Acquired	(price as of 2026-08-20)
May 7, 2014	SCYX	C	42,336	—	—	214,495 Direct	+24.59%	Acquired	(price as of 2026-08-20)
May 7, 2014	SCYX	C	88,796	—	—	172,159 Direct	+106.52%	Acquired	(price as of 2026-08-20)
May 7, 2014	SCYX	C	46,863	—	—	83,363 Direct	+128.39%	Acquired	(price as of 2026-08-20)
May 7, 2014	SCYX	X	25,998	$0.20	$5,200	36,500 Direct	+247.55%	Acquired	-67.1% (price as of 2026-08-20)
May 7, 2014	SCYX	X	5,251	$0.20	$1,050	10,502 Direct	+100.00%	Acquired	-67.1% (price as of 2026-08-20)
May 7, 2014	SCYX	X	5,251	$0.20	$1,050	5,251 Direct	—	Acquired	-67.1% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
May 7, 2014	SCYX	Series D-2 Preferred Stock	Common Stock (30,582)	—	—	623,880	Disposed
May 7, 2014	SCYX	Series D-1 Preferred Stock	Common Stock (42,336)	—	—	863,672	Disposed
May 7, 2014	SCYX	Series C Preferred Stock	Common Stock (88,796)	—	—	313,996	Disposed
May 7, 2014	SCYX	Series B Preferred Stock	Common Stock (46,863)	—	—	166,482	Disposed
May 7, 2014	SCYX	Common Stock Warrant (right to buy)	Common Stock (25,998)	$0.20	Dec. 10, 2018	25,998	Disposed
May 7, 2014	SCYX	Common Stock Warrant (right to buy)	Common Stock (5,251)	$0.20	May 14, 2017	5,251	Disposed
May 7, 2014	SCYX	Common Stock Warrant (right to buy)	Common Stock (5,251)	$0.20	Dec. 6, 2016	5,251	Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
May 2, 2014	SCYX	Common Stock Warrant (right to buy)→ Common Stock (5,251)	5,251	Direct
May 2, 2014	SCYX	Common Stock Warrant (right to buy)→ Common Stock (5,251)	5,251	Direct
May 2, 2014	SCYX	Common Stock Warrant (right to buy)→ Common Stock (25,998)	25,998	Direct
May 2, 2014	SCYX	Series B Preferred Stock→ Common Stock	—	Direct
May 2, 2014	SCYX	Series C Preferred Stock→ Common Stock	—	Direct
May 2, 2014	SCYX	Series D-1 Preferred Stock→ Common Stock	—	Direct
May 2, 2014	SCYX	Series D-2 Preferred Stock→ Common Stock	—	Direct